Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes.
Antithrombotic and antiplatelet drugs and percutaneous interventions have decreased the ischemic outcomes of non-ST-elevation acute coronary syndromes, but they pose risks of bleeding. The authors review the scope of the problem and ways to prevent and manage bleeding in this situation.
Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA. antonio.gutierrez@duke.edu
Antonio
A
Gutierrez
Sunil V
SV
Rao
D054058:Acute Coronary Syndrome / Q000150:complications* / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006470:Hemorrhage / Q000139:chemically induced* / Q000209:etiology*; D006801:Humans; D015994:Incidence; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011379:Prognosis; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors